WS-019

N/A

Report date: 2025/07/18 11:10:35

Base Information

Drug NameWS-019
Drug Alias NameWS-019WS019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHubei Wushi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHubei Wushi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A